Is there clinical benefit to routine enzyme testing of patients on statins?

Bibliography

• Heart Disease and Stroke Statistics—2003 Update. American Heart Association. Dallas, TX; 2003. Public-use data file and documentation. Available from: http://www.americanheart.org/downloadable/heart/1040391091015HDS_Stats_03.pdf
   Google Scholar
• Baigent C, Keech A, Kearney PM, Cholesterol Treatment Trialists′ (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493):1267-78
   PubMed Web of Science ®Google Scholar
• Gillett RC Jr, Norrell A. Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicitiy. Am Fam Physician 2011;15:83(6):711-16
   Google Scholar
• Athyros VG, Tziomalos K, Gossios TD, GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010;376:1916-22
   PubMed Web of Science ®Google Scholar
• Brown WV. Safety of statins. Curr Opin Lipidol 2008;19:558-62
   PubMed Web of Science ®Google Scholar
• Bader T. The myth of statin-induced hepatotoxicity. Am J Gastroenterol 2010;105:978-80
   PubMed Web of Science ®Google Scholar
• Pasternak RC, Smith SC Jr, Bairey-Merz CN, ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Stroke 2002;3:2337-41
   Web of Science ®Google Scholar
• Onusko E. Statins and elevated liver tests: what′s the fuss? J Fam Pract 2008;57:449-52
   PubMed Web of Science ®Google Scholar
• Pasternak RC, Smith SC Jr, Bairey-Merz CN, ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. Circulation 2002;106(8):1024-8
   PubMed Web of Science ®Google Scholar
• Sniderman AD. Is there value in liver function test and creatine phosphokinase monitoring with statin use? Am J Cardiol 2004;94:30-4
   PubMed Web of Science ®Google Scholar
• Rzouq FS, Volk ML, Hatoum HH, Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians. Am J Med Sci 2010;340:89-93
   PubMed Web of Science ®Google Scholar
• Vinker S, Baevsky T, Shani M, Elhayany A. Predictors of adherence with statins in a usual care setting: a retrospective database analysis over 8 years. The 14th annual Conference of the Israeli Society of Quality in Health; May 2007; Ramat Gan, Israel
   Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel (ATP III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421
   PubMed Web of Science ®Google Scholar
• Snow V, Aronson MD, Hornbake ER, Clinical efficacy assessment subcommittee of the American college of physicians. Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2004;140:644-9
   PubMed Web of Science ®Google Scholar
• Thompson PD, Clarkson P, Karas RH. Statin-Associated Myopathy. JAMA 2003;289:1681-90
   PubMed Web of Science ®Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31
   PubMed Web of Science ®Google Scholar
• Zamor PJ, Russo MW. Liver function tests and statins. Curr Opin Cardiol 2011; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Liver function test monitoring with simvastatin. [Data on file]. Merck & Co. Inc; West Point, PA: 2004
   Google Scholar
• Russo MW, Watkins PB. Are patients with elevated liver tests at increased risk of drug-induced liver injury? Gastroenterology 2004;126:1477-80
   PubMed Web of Science ®Google Scholar
• Tolman KG. The liver and lovastatin. Am J Cardiol 2002;89:1374-80
   PubMed Web of Science ®Google Scholar
• Chalasani N, Aljadhey H, Kesterson J, Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology 2004;26:1287-92
   Web of Science ®Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31
   PubMed Web of Science ®Google Scholar
• Harper CR, Jacobson TA. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol 2007;18:401-8
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Allen J, Blair SN, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72
   PubMed Web of Science ®Google Scholar
• Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003;289:1681-90
   PubMed Web of Science ®Google Scholar